Entheon Biomedical Corp. (ENBI.CN)

0.1600 +0.0050 (+3.23%) At close: 11:30AM EDT

Entheon Biomedical Corp.

999 West Broadway
Suite 720
Vancouver, BC V5Z 1K5
Canada
604-562-3932
https://www.entheonbiomedical.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 2

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Timothy Ko	President, CEO & Director	130k	N/A	1986
Mr. Soo-Whan Kim	Interim Chief Financial Officer	N/A	N/A	N/A
Dr. Brian E. Jahns Pharm.D.	Chief Business Officer	N/A	N/A	N/A
Ms. Kelly Pladson	Corporate Secretary	N/A	N/A	1983

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Entheon Biomedical Corp. operates as a biotechnology research and development company. It engages in developing of products for treating addiction and substance use disorders. The company is headquartered in Vancouver, Canada.

Corporate Governance

Entheon Biomedical Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.